KPV^↗

"KPV"[Title/Abstract] OR "Lys-Pro-Val"[Title/Abstract]

• All 128 records returned by this exact title/abstract query were screened for administration of the defined KPV tripeptide to people. None met that criterion; this does not establish absence outside this query.
• Citation follow-up, other aliases, trial registries and non-indexed reports remain separate coverage work. Preclinical evidence and related molecules require their own scopes.

Showing 25 of 128 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.

1. PubMed 42585803 — exclude: Laboratory, structural, cell/tissue or animal research in the inspected abstract; no administration of the defined KPV tripeptide to people is described.
2. PubMed 42064835 — exclude: Laboratory, structural, cell/tissue or animal research in the inspected abstract; no administration of the defined KPV tripeptide to people is described.
3. PubMed 41880199 — exclude: Secondary overview of mechanisms or potential applications; not a primary human-administration report.
4. PubMed 41533788 — exclude: Laboratory, structural, cell/tissue or animal research in the inspected abstract; no administration of the defined KPV tripeptide to people is described.
5. PubMed 41241376 — exclude: Secondary overview of mechanisms or potential applications; not a primary human-administration report.
6. PubMed 41209547 — exclude: Secondary overview of mechanisms or potential applications; not a primary human-administration report.
7. PubMed 40935835 — exclude: Laboratory, structural, cell/tissue or animal research in the inspected abstract; no administration of the defined KPV tripeptide to people is described.
8. PubMed 40073467 — exclude: Laboratory, structural, cell/tissue or animal research in the inspected abstract; no administration of the defined KPV tripeptide to people is described.
9. PubMed 40030207 — exclude: Laboratory, structural, cell/tissue or animal research in the inspected abstract; no administration of the defined KPV tripeptide to people is described.
10. PubMed 39252648 — exclude: Laboratory, structural, cell/tissue or animal research in the inspected abstract; no administration of the defined KPV tripeptide to people is described.
11. PubMed 39211778 — exclude: Laboratory, structural, cell/tissue or animal research in the inspected abstract; no administration of the defined KPV tripeptide to people is described.
12. PubMed 38289234 — exclude: Laboratory, structural, cell/tissue or animal research in the inspected abstract; no administration of the defined KPV tripeptide to people is described.
13. PubMed 38041747 — exclude: Different molecule, longer sequence, acronym or name match; not administration of the defined KPV tripeptide to people.
14. PubMed 37860176 — exclude: Different molecule, longer sequence, acronym or name match; not administration of the defined KPV tripeptide to people.
15. PubMed 37859689 — exclude: Full-text eligibility review identifies male C57BL/6J mice in the KPV-conjugate acute and chronic colitis experiments (sections 2.5.4 and 2.5.5); not administration to people.
    Full-text eligibility check · PMC10582360

    Read the source full text ↗ · sections 2.5.4, 2.5.5.

    This reading establishes eligibility for this search; it is not a full appraisal of the study.

    Reviewed 2026-09-15; source SHA-256 7a3158245d0f6a0d4d23c128e6d9b41efb84e006120275de1deb364f466ceb1a.

16. PubMed 37508552 — exclude: Secondary overview of mechanisms or potential applications; not a primary human-administration report.
17. PubMed 37161053 — exclude: Different molecule, longer sequence, acronym or name match; not administration of the defined KPV tripeptide to people.
18. PubMed 36240893 — exclude: Laboratory, structural, cell/tissue or animal research in the inspected abstract; no administration of the defined KPV tripeptide to people is described.
19. PubMed 35496263 — exclude: Different molecule, longer sequence, acronym or name match; not administration of the defined KPV tripeptide to people.
20. PubMed 35245681 — exclude: Laboratory, structural, cell/tissue or animal research in the inspected abstract; no administration of the defined KPV tripeptide to people is described.
21. PubMed 34846053 — exclude: Laboratory, structural, cell/tissue or animal research in the inspected abstract; no administration of the defined KPV tripeptide to people is described.
22. PubMed 34662120 — exclude: Laboratory, structural, cell/tissue or animal research in the inspected abstract; no administration of the defined KPV tripeptide to people is described.
23. PubMed 34547895 — exclude: Laboratory, structural, cell/tissue or animal research in the inspected abstract; no administration of the defined KPV tripeptide to people is described.
24. PubMed 32004526 — exclude: Laboratory, structural, cell/tissue or animal research in the inspected abstract; no administration of the defined KPV tripeptide to people is described.
25. PubMed 31408067 — exclude: Laboratory, structural, cell/tissue or animal research in the inspected abstract; no administration of the defined KPV tripeptide to people is described.

products.active_ingredients.name:"KPV"

• Zero results describe this query response only, not absence of FDA approval or worldwide nonapproval.
• This endpoint does not inventory every label, advisory proceeding, safety communication or regulatory document. Application inclusion does not establish current marketing or approval of every use.

Showing 0 of 0 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.

Case-insensitive word-boundary identity terms: ["KPV", "Lys-Pro-Val"]

• Document appraisal and national European sources remain open.
• Zero matches apply only to these feed fields and terms; orphan designation is not approval.

Showing 0 of 0 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.

Case-insensitive word-boundary identity terms: ["KPV", "Lys-Pro-Val"]

• Document appraisal and national European sources remain open.
• Zero matches apply only to these feed fields and terms; orphan designation is not approval.

Showing 0 of 0 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.

Case-insensitive word-boundary identity terms: ["KPV", "Lys-Pro-Val"]

• Document appraisal and national European sources remain open.
• Zero matches apply only to these feed fields and terms; orphan designation is not approval.

Showing 0 of 0 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.

"KPV" OR "Lys-Pro-Val"

• Registration is not evidence that a study succeeded, that results were published, or that a use is approved.
• Other registries, unregistered studies and additional aliases remain outside this query.

Showing 0 of 0 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.